From: | Becker's Supply Chain Report <editorial@beckershealthcare.com> |
Subject: | EpiPens priced up to $700, controversy ensues | Clinton vs. Trump: 16 quotes on healthcare from the presidential candidates | Premier reports 13% net revenue increase in Q4 | FDA: Drug companies abuse citizen petitions to block generic competition |
Preheader: | |
Reply: | editorial@beckershealthcare.com |
|